Skip to main content
BeOne Medicines AG (ONC)
NASDAQ: ONC · Real-Time Price · USD
316.99
-5.38 (-1.67%)
At close: Feb 27, 2026, 4:00 PM EST
317.01
+0.02 (0.01%)
After-hours: Feb 27, 2026, 5:21 PM EST

BeOne Medicines AG Revenue

In the year 2025, BeOne Medicines AG had annual revenue of $5.34B with 40.23% growth. BeOne Medicines AG had revenue of $1.50B in the quarter ending December 31, 2025, with 32.84% growth.

Revenue (ttm)
$5.34B
Revenue Growth
+40.23%
P/S Ratio
6.58
Revenue / Employee
$485,730
Employees
11,000
Market Cap
35.17B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20255.34B1.53B40.23%
Dec 31, 20243.81B1.35B54.96%
Dec 31, 20232.46B1.04B73.65%
Dec 31, 20221.42B239.64M20.37%
Dec 31, 20211.18B867.41M280.83%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Regeneron Pharmaceuticals 14.34B
Incyte 5.14B
argenx SE 4.25B
Genmab 3.72B
Alnylam Pharmaceuticals 3.71B
BioNTech SE 3.70B
Royalty Pharma 2.38B
Moderna 1.94B
Revenue Rankings

ONC News

More News